NCT07025772 (SHIFTS) is a NA clinical trial of ST+ABR in ST+ABR, sponsored by University of Houston.

Who is sponsoring NCT07025772?

NCT07025772 is sponsored by University of Houston.

What drugs are being tested in NCT07025772?

Interventions in NCT07025772: ST+ABR, ST+Sham, ST Only.

What condition does NCT07025772 study?

NCT07025772 studies ST+ABR, ST+SHAM, ST-only.

Is NCT07025772 still recruiting?

NCT07025772 is currently recruiting now. Last updated 17 April 2026.

Last reviewed 2026-04-17 · How we verify

NCT07025772: SHIFTS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Shaping Habitual Impulses For a Tobacco-free Style

Recruiting now NA Last updated 17 April 2026

What this trial tests

NA trial testing ST+ABR in ST+ABR in 300 participants. Currently enrolling.

Timeline

24 March 2026

Primary endpoint
1 November 2028

1 February 2029

Quick facts

Lead sponsor	University of Houston
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	300
Start date	24 March 2026
Primary completion	1 November 2028
Estimated completion	1 February 2029
Sites	1 location across United States

Drugs / interventions tested

ST+ABR
ST+Sham
ST Only

Conditions studied

ST+ABR — all drugs for ST+ABR →
ST+SHAM — all drugs for ST+SHAM →
ST-only — all drugs for ST-only →

Sponsor

University of Houston

Who can join

18 and older, any sex, with ST+ABR or ST+SHAM. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The present investigation aims to assess the efficacy of an innovative and novel smoking cessation intervention that integrates approach bias retraining (ABR) and standard smoking cessation treatment (ST). Participants will be randomized to either: (1) standard smoking cessation treatment and approach bias retraining (ST+ABR); (2) ST+Sham; or (3) ST-only.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other University of Houston trials

Trials by the same sponsor.

NCT07024992 — Enhancing Smoking Cessation for African American People Everywhere · Phase 2 · not yet recruiting
NCT07007195 — Smart Olfaction App to Reduce Relapse · EARLY_PHASE1 · not yet recruiting
NCT06918821 — Reducing Obesity Through Play Among Toddlers: Tiny Steps to Health (TSHS) Study · NA · recruiting
NCT07227220 — Summer Youth Employment Programs for Health Promotion · EARLY_PHASE1 · completed
NCT06866223 — Emergent Bilinguals: Child Language Proficiency and Language of Treatment · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07025772 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Houston
Last refreshed: 17 April 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07025772.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing